Close
Close
Treatment Database
Recombinant fully human IgG1 monoclonal antibody targeted to the Zaire ebolavirus glycoprotein
Trade Name not avaiable
Orphan Indication Ebola Virus Disease
USA Market Approval
USA Designation Date 08-05-2019
Sponsor Ridgeback Biotherapeutics, LP
3162 Commodore Plaza, Suite 3E
Coconut Grove, Florida, 33133
More about Ebola
Free Newsletter
Related Videos